基于证据的评分系统:用于植入前遗传学筛查后对嵌合非整倍体胚胎进行移植优先级排序
本研究基于单中心72,472例绒毛膜绒毛样本和3806例流产物的细胞遗传学与分子结果进行回顾性分析,构建了一套证据评分系统,用于对植入前遗传学筛查检出的嵌合非整倍体胚胎进行移植优先级排序。复合评分越高,移植优先级越低。由于缺乏针对嵌合非整倍体胚胎实际移植的前瞻性研究,作者建议使用该评分系统为临床医生、胚胎学家和患者提供实用工具。
要点
- 基于绒毛膜绒毛样本和流产物的细胞遗传学与分子结果构建嵌合非整倍体胚胎移植优先级评分系统。
- 复合评分越高,胚胎移植优先级越低。
- 因缺乏嵌合非整倍体胚胎实际移植的前瞻性研究,作者建议使用该评分系统作为实用工具。
核心结论
- 由于缺乏针对嵌合非整倍体胚胎实际移植的前瞻性研究,作者建议使用该基于证据的评分系统,为临床医生、胚胎学家和患者提供实用工具。
研究设计与样本
- 回顾性分析单中心全部连续的绒毛膜绒毛样本(n=72,472)和流产物(n=3806)的细胞遗传学与分子结果。
主要发现
- 利用绒毛膜绒毛样本中检测到的嵌合非整倍体累及胎儿的可能性、绒毛膜绒毛嵌合状态下临床显著胎儿单亲二体的发生率以及嵌合体导致流产的几率,生成评分系统。
- 根据每种不良结局的发生率/可能性为每个嵌合非整倍体分配个体风险评分后,获得复合评分。
- 对具有明确表型的存活完全或嵌合非整倍体给予最终额外评分。
- 复合评分越高,胚胎移植优先级越低。
临床怎么用
- 作者建议使用该基于证据的评分系统,为临床医生、胚胎学家和患者提供实用工具,用于对植入前遗传学筛查检出的嵌合非整倍体胚胎进行移植优先级排序。
局限性
- 原文指出缺乏针对嵌合非整倍体胚胎实际移植的前瞻性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The aim of this study was to devise an evidence-based scoring system for prioritizing mosaic aneuploid embryos for transfer. A retrospective analysis was performed of all sequential cytogenetic and molecular results on chorionic villi samples (n = 72,472) and products of conception (n = 3806) analysed at a single centre. The likelihood that a mosaic aneuploidy detected in chorionic villi samples will involve the fetus, the incidence of clinically significant fetal uniparental disomy in the presence of a mosaic in chorionic villi and the chance of the mosaicism culminating in miscarriage were used to generate a scoring system for prioritizing mosaic aneuploid embryos detected by preimplantation genetic screening. A composite score was obtained for each individual mosaic aneuploidy after assignment of an individual risk score based on the incidence/likelihood of each adverse outcome. A final additional score was assigned to viable full or mosaic aneuploidies with a well-defined phenotype. The higher the composite score the lower the priority for embryo transfer. In conclusion, due to the paucity of prospective studies on the actual transfer of mosaic aneuploid embryos, we suggest using this evidence-based scoring system to provide a useful tool for clinicians, embryologists and patients.
引用
- Grati FR, Gallazzi G, Branca L, et al. An evidence-based scoring system for prioritizing mosaic aneuploid embryos following preimplantation genetic screening. Reprod Biomed Online. 2018. PMID: 29433970. doi:10.1016/j.rbmo.2018.01.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。